Europe — EMA
Noradrenaline Sans Conservateur Renaudin (Noradrenaline Tartrate)
GNH USA supplies Noradrenaline Renaudin (noradrenaline tartrate), a vasopressor for hypotension and septic shock. Request a quote for global supply.
Request sourcing
What is Noradrenaline Tartrate?
Noradrenaline tartrate, the active ingredient in Noradrenaline Sans Conservateur Renaudin, is an alpha-adrenergic agonist presented as an injectable solution for intravenous use. It is employed to raise blood pressure in patients experiencing hypotension, including those in septic shock.
GNH USA supplies Noradrenaline Sans Conservateur Renaudin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.
What is Noradrenaline Tartrate used for?
Noradrenaline tartrate acts as a potent vasopressor in critical‑care settings, targeting severe hypotensive states.
- Hypotension: restores vascular tone and raises arterial pressure in acute low‑blood‑pressure states. - Septic shock: counteracts profound vasodilation and supports organ perfusion in septic patients. - Vasodilatory shock: provides vasoconstriction to improve systemic vascular resistance when other agents are insufficient.
What are the side effects of Noradrenaline Tartrate?
Adverse reactions may vary with dose and patient condition.
Common Side Effects: - Headache: mild to moderate pain often related to rapid blood‑pressure changes. - Tachycardia: increased heart rate due to reflex mechanisms. - Arrhythmia: irregular heart rhythms, especially at high infusion rates. - Hypertension: excessive rise in blood pressure if over‑titrated. - Peripheral ischemia: reduced blood flow to extremities causing coldness or discoloration. - Nausea: gastrointestinal discomfort reported in some patients.
Serious or Rare Side Effects: - Myocardial ischemia: reduced coronary blood flow leading to chest pain or infarction. - Severe hypertension: dangerously high blood pressure that may cause vascular injury. - Tissue necrosis at infusion site: local tissue death if extravasation occurs. - Life‑threatening arrhythmias: ventricular tachycardia or fibrillation. - Pulmonary edema: fluid accumulation in lungs due to abrupt hemodynamic shifts.
What precautions apply to Noradrenaline Tartrate?
When using noradrenaline, careful monitoring and specific precautions are essential.
- Dose titration: adjust infusion rate to achieve target mean arterial pressure while avoiding overshoot. - Cardiac monitoring: continuously observe ECG for arrhythmias or ischemic changes. - Peripheral perfusion: inspect infusion sites regularly for signs of ischemia or extravasation. - Pregnancy and lactation: use only if potential benefits justify potential risks to the fetus or infant. - Concomitant MAO inhibitors: avoid because of heightened risk of hypertensive crisis. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze, and use within the labeled shelf‑life.
What does Noradrenaline Tartrate interact with?
Noradrenaline may interact with several drug classes, requiring vigilance.
Major Interactions (Avoid): - MAO inhibitors: can precipitate severe hypertension. - Beta‑blockers: may blunt the expected tachycardic response. - Tricyclic antidepressants: additive vasoconstrictive effect increasing blood‑pressure risk.
Moderate Interactions (Monitor Closely): - Vasodilators (e.g., nitroglycerin): may necessitate higher noradrenaline doses. - Calcium channel blockers: can increase the likelihood of bradycardia when combined. - Inhaled anesthetics: may potentiate hypotensive effects, requiring dose adjustments.



